July 3, 2021 12:45pm

NTLA closed down -$7.94 to $163.71

Raised approximately $690 million with a full exercise of 620,689 share option



Intellia Therapeutics (NTLA) completed its offering with a huge upside ...

With bragging rights as to pricing and the closing share pricing as well as the amount raised

Goldman Sachs & Co. LLC, Jefferies, SVB Leerink and Barclays are acting as joint book-running managers for the proposed offering. Truist Securities acted as co-manager for the offering.


The offering close July 2, 2021.